Cantley Lewis Clayton Jr. 4
4 · AGIOS PHARMACEUTICALS INC · Filed Oct 18, 2017
Insider Transaction Report
Form 4
Cantley Lewis Clayton Jr.
Director10% Owner
Transactions
- Sale
Common stock
2017-10-16$71.09/sh−1,000$71,090→ 84,434 total(indirect: See footnote) - Sale
Common stock
2017-10-17$71.10/sh−1,000$71,100→ 83,394 total - Sale
Common stock
2017-10-16$71.09/sh−1,000$71,090→ 84,394 total - Sale
Common stock
2017-10-17$71.10/sh−1,000$71,100→ 83,434 total(indirect: See footnote)
Holdings
- 20,803(indirect: See footnote)
Common stock
- 20,803(indirect: See footnote)
Common stock
Footnotes (6)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $70.58 to $71.83. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F3]Shares held by Vicki Lee Sato, who is the reporting person's spouse.
- [F4]The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $70.71 to $71.51. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F5]Shares held by grantor retained annuity trusts for the benefit of the reporting person and his two children, of which the reporting person is trustee and sole annuitant.
- [F6]Shares held by grantor retained annuity trusts for the benefit of the reporting person's spouse and their two children, of which the reporting person's spouse is trustee and sole annuitant.